Literature DB >> 12106601

Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants.

Katharina Wenzel-Seifert1, Hui Yu Liu, Roland Seifert.   

Abstract

The human beta1-adrenoceptor (beta1AR) and beta2-adrenoceptor (beta2AR) couple to Gs-proteins to activate adenylyl cyclase (AC). There are differences in desensitization between the beta2AR and the originally cloned Gly389-beta1AR, but with respect to ternary complex formation, constitutive activity, and AC activation the picture is unclear. To learn more about the similarities and differences between the beta1AR and beta2AR, we analyzed coupling of the Gly389-beta1AR to the G(s(alpha)) splice variants Gs(alpha)L and Gs(alpha)S using beta1AR-Gs(alpha) fusion proteins expressed in Sf9 cells and compared the data with previously published data on beta2AR-Gs(alpha) fusion proteins (Seifert et al., J Biol Chem 1998;273:5109-16). Fusion ensures defined receptor/G-protein stoichiometry and efficient coupling. The agonist (-)-isoproterenol stabilized the ternary complex at beta1AR-Gs(alpha)S, beta1AR-Gs(alpha)L, beta2AR-Gs(alpha)S, and beta2AR-Gs(alpha)L with similar efficiency. beta1AR-Gs(alpha)L but not beta1AR-Gs(alpha)S showed the hallmarks of constitutive activity as assessed by increased potencies and efficacies of partial agonists and AC activation by the agonist-free receptor. Similar differences were observed previously for beta2AR-Gs(alpha)S and beta2AR-Gs(alpha)L. beta1AR-Gs(alpha)S and beta2AR-Gs(alpha)S were similarly efficient at activating AC, but beta1AR-Gs(alpha)L was approximately 4-fold more efficient at activating AC than beta2AR-Gs(alpha)L. Our data show that (i) the beta1AR and beta2AR are similarly efficient at stabilizing the ternary complex with Gs(alpha) splice variants, (ii) Gs(alpha)L confers constitutive activity to the beta1AR and beta2AR, and (iii) the beta1AR coupled to Gs(alpha)L is more efficient at activating AC than the beta2AR coupled to Gs(alpha)L. These data help us understand some of the discrepancies regarding similarities and differences between the beta1AR and beta2AR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106601     DOI: 10.1016/s0006-2952(02)00924-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Coupling of beta2-adrenoceptors to XLalphas and Galphas: a new insight into ligand-induced G protein activation.

Authors:  A I Kaya; O Ugur; S S Oner; M Bastepe; H O Onaran
Journal:  J Pharmacol Exp Ther       Date:  2009-01-14       Impact factor: 4.030

2.  Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia.

Authors:  Gonghao He; Jing Hu; Teng Li; Xue Ma; Jingru Meng; Min Jia; Jun Lu; Hiroshi Ohtsu; Zhong Chen; Xiaoxing Luo
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 3.  Pharmacogenomics of cardiovascular complications in diabetes and obesity.

Authors:  Kalyan Chapalamadugu; Siva K Panguluri; Aimon Miranda; Kevin B Sneed; Srinivas M Tipparaju
Journal:  Recent Pat Biotechnol       Date:  2014

4.  Cannabinoid modulation of cortical adrenergic receptors and transporters.

Authors:  B A S Reyes; J C Rosario; P M T Piana; E J Van Bockstaele
Journal:  J Neurosci Res       Date:  2009-12       Impact factor: 4.164

5.  Biochemical evidence for a P2Y-like receptor in Tetrahymena thermophila.

Authors:  B N Rosner; J N Bartholomew; C D Gaines; M L Riddle; H A Everett; K G Rulapaugh; L E Nickerson; M R Marshall; H G Kuruvilla
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2003-09-06       Impact factor: 1.836

6.  Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells.

Authors:  Sher Zaman Safi; Rajes Qvist; Gracie Ong Siok Yan; Ikram Shah Bin Ismail
Journal:  BMC Med Genomics       Date:  2014-05-30       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.